Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02538627
Title Phase 1 Combination Study of MM-151 and MM-121
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merrimack Pharmaceuticals
Indications

head and neck cancer

colorectal cancer

lung cancer

Therapies

Seribantumab

MM-151

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Aurora Colorado 80045 United States Details
Northside Hospital Sandy Springs Georgia 30342 United States Details
Northwestern Chicago Illinois 60611 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Vanderbilt Nashville Tennessee 37235 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field